Safety, Tolerability, and Immunogenicity of ALFQ in a HIV Vaccine Containing A244 and B.65321 in Healthy Adults

Clinical trial NCT05423418 · COMPLETED

Trial details

NCT number: NCT05423418
Sponsor: U.S. Army Medical Research and Development Command
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Human Immunodeficiency Virus (HIV)AIDS Virus

Start date: 2022-09-08
Primary completion: 2024-10-29
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.